Publications in collaboration with researchers from University of Florence (56)

2025

  1. Structural and magnetic properties of high magnetization FexCo100-x nanoparticles investigated at the nanoscale: Unveiling the origin of the observed anisotropy

    Journal of Alloys and Compounds, Vol. 1010

2024

  1. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 348-357

  2. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  3. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

    Brain Communications, Vol. 6, Núm. 4

  4. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

  5. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study

    Journal of Neurology, Neurosurgery and Psychiatry

  6. Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

    Leukemia, Vol. 38, Núm. 10, pp. 2259-2265

2023

  1. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

    Cochrane Database of Systematic Reviews, Vol. 2023, Núm. 3

  2. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

    Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700

  3. Disability accrual in primary and secondary progressive multiple sclerosis

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 9, pp. 707-717

  4. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  5. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1573-1586

  6. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  7. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

    Brain, Vol. 146, Núm. 1, pp. 321-336

  8. Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey

    World Journal of Emergency Surgery, Vol. 18

  9. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1947-1962

  10. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

    Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644

2022

  1. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 11, pp. 1764-1777

  2. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

    Alzheimer's and Dementia, Vol. 18, Núm. 7, pp. 1408-1423

  3. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1